webinar register page

KOL Webinar on VIP152 for the Treatment of Hematologic and Solid Tumors, hosted by Vincerx
The event will feature a presentation by Key Opinion Leaders (KOLs) Ian Flinn, M.D., Ph.D. (Sarah Cannon Center for Blood Cancer), John Byrd, M.D. (The Ohio State University), and Howard "Skip" Burris III, M.D. (Sarah Cannon) who will discuss the CDK9 inhibitor landscape in hematologic and solid tumors. Drs. Flinn, Byrd, and Burris will be available to answer questions following the formal presentations.


* Required information